论文部分内容阅读
阴道内占优势的乳酸杆菌的存在与细菌性阴道病和泌尿生殖道感染的患病风险下降有关,作用机制包括:多种抗黏附因子、代谢产物如对多数病原体有杀伤力的过氧化氢和细菌素、还可能存在免疫调节等作用。口服或向阴道内注入乳酸杆菌GR-1和RC-14型可以将阴道内的菌群调节到一个正常状态,维持泌尿生殖道内的正常菌群,降低泌尿道感染的患病率。现代医学研究应从药物作为疾病治疗的唯一途径的传统观念中转变过来。
The presence of vaginally dominant Lactobacilli is associated with a reduction in the prevalence of bacterial vaginosis and genitourinary infections, with mechanisms of action including a variety of anti-adhesion factors, metabolites such as hydrogen peroxide that is lethal to most pathogens and Bacteriocins, but also the role of immune regulation may exist. Oral or intravaginal injection of Lactobacilli GR-1 and RC-14 type of vaginal flora can be adjusted to a normal state, to maintain normal genitourinary tract flora, reduce the prevalence of urinary tract infections. Modern medical research should shift from the traditional notion that medicine is the only way to treat disease.